AlphaFold predicted structure
SLC2A9 · Q9NRM0

Mean pLDDT
82.6/ 100
Confident
540 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)33%
- Low(50–70)2%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 2 member 9
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Nephrocalcinosis or nephrolithiasis
BOTH monoallelic and biallelic, autosomal or pseudoautosomalRenal tubulopathies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalAcute rhabdomyolysis
BOTH monoallelic and biallelic, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalhypouricemia, renal, 2
gout
hyperuricemia
alcohol drinking
hereditary renal hypouricemia
physical activity
renal tubular transport disease
arthropathy
chronic kidney disease
bladder calculus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Solute carrier family 2, facilitated glucose transporter member 9
High-capacity urate transporter, which may play a role in the urate reabsorption by proximal tubules (PubMed:18327257, PubMed:18701466, PubMed:22647630, PubMed:28083649, PubMed:36749388). May have a residual high-affinity, low-capacity glucose and fructose transporter activity (PubMed:18327257, PubMed:18701466, PubMed:18842065). Transports urate at rates 45- to 60-fold faster than glucose (PubMed:18842065). Does not transport galactose (PubMed:28083649). May mediate small uptake of adenine but not of other nucleobases (PubMed:22647630)
Curated MONDO disease pages that list SLC2A9 among their top associated genes.
SLC2A9 · Q9NRM0

Mean pLDDT
82.6/ 100
Confident
540 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0